
Top 5 Infectious Disease News Stories Week of March 1-8
In February 2025, several key FDA approvals and updates in infectious disease included the approval of Bavarian Nordic’s Vimkunya vaccine for chikungunya, providing a single-dose option for those aged 12 and older. The FDA also approved GSK's Penmenvy …